Zurcher Kantonalbank (Zurich Cantonalbank) - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 63 filers reported holding PROQR THRAPEUTICS N V in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2022$3,0000.0%3,8190.0%0.00%
Q2 2022$3,0000.0%3,8190.0%0.00%
Q1 2022$3,000
-88.0%
3,819
-13.7%
0.00%
Q3 2019$25,000
-37.5%
4,4260.0%0.00%
Q2 2019$40,000
-14.9%
4,426
+32.0%
0.00%
Q1 2019$47,000
-11.3%
3,3540.0%0.00%
-100.0%
Q4 2018$53,0003,3540.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2022
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$18,010,7836.83%
M28 Capital Management LP 1,910,600$7,069,2206.74%
Opaleye Management Inc. 1,460,000$5,402,0001.88%
Ikarian Capital, LLC 422,625$1,563,7130.38%
Monaco Asset Management SAM 165,000$610,5000.18%
AWM Investment Company, Inc. 166,667$616,6680.09%
FRANKLIN STREET ADVISORS INC /NC 150,000$5550.05%
Atom Investors LP 18,522$68,5310.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$13,414,2280.03%
GSA CAPITAL PARTNERS LLP 21,514$800.01%
View complete list of PROQR THRAPEUTICS N V shareholders